This is a final reminder that the patient/consumer submissions to PBAC (Pharmaceutical Benefits Advisory Committee) close at 11pm on Wednesday 29 January 2025!
Make your submission(s) via the online form here.
These submissions will contribute to the PBAC meeting in March where they will consider 4 new treatments for Myasthenia Gravis (MG) being available and accessible in Australia.
Please see the MAA news feed through December and January for information on the 4 new treatments and guidance on how to make your submissions.
Thank you to everyone who has already made a submission and contributed to this once in a generation opportunity for Myasthenia patients in Australia.